Multiple Assemblies exist for SMTL entry 5iz0
RORgamma in complex with agonist BIO592 and Coactivator EBI96; X-RAY DIFFRACTION 2.63 Å

	SMTL ID 5iz0.1 Ligands N-(4-ethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)-3,4-dimethyl-N-(2,2,2-trifluoroethyl)benzene-1-sulfonamide; CHLORIDE ION Polypeptides Nuclear receptor ROR-gamma; GLU-PHE-PRO-TYR-LEU-LEU-SER-LEU-LEU-GLY-GLU-VAL-SER-PRO-GLN Oligo-state hetero-1-1-mer
	SMTL ID 5iz0.2 Ligands N-(4-ethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)-3,4-dimethyl-N-(2,2,2-trifluoroethyl)benzene-1-sulfonamide; CHLORIDE ION Polypeptides Nuclear receptor ROR-gamma; GLU-PHE-PRO-TYR-LEU-LEU-SER-LEU-LEU-GLY-GLU-VAL-SER-PRO-GLN Oligo-state hetero-1-1-mer
	SMTL ID 5iz0.3 Ligands N-(4-ethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)-3,4-dimethyl-N-(2,2,2-trifluoroethyl)benzene-1-sulfonamide; CHLORIDE ION Polypeptides Nuclear receptor ROR-gamma; GLU-PHE-PRO-TYR-LEU-LEU-SER-LEU-LEU-GLY-GLU-VAL-SER-PRO-GLN Oligo-state hetero-1-1-mer
	SMTL ID 5iz0.4 Ligands N-(4-ethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)-3,4-dimethyl-N-(2,2,2-trifluoroethyl)benzene-1-sulfonamide; CHLORIDE ION Polypeptides Nuclear receptor ROR-gamma; GLU-PHE-PRO-TYR-LEU-LEU-SER-LEU-LEU-GLY-GLU-VAL-SER-PRO-GLN Oligo-state hetero-1-1-mer